
Akero Therapeutics, Inc.
USD54.65
+0.00 (+0.00%)
CEO
Andrew Cheng
IPO Date
2019-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$54.52
Prev. Close
$54.65
Day Low
$54.52
Day High
$54.65
52W Low
$21.34
52W High
$58.40
Market Cap
$4.50B
Volume
11.61M
| 9 Oct 2025 |
| Canaccord Genuity |
| Buy |
| Hold |
| downgrade |
| 27 May 2025 | B of A Securities | Buy | Buy | maintain |
| 13 May 2025 | Citigroup | Buy | Buy | maintain |
| 3 Mar 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 31 Jan 2025 | UBS | Buy | Buy | maintain |
| 30 Jan 2025 | B of A Securities | Neutral | Buy | upgrade |
| 27 Jan 2025 | HC Wainwright & Co. | Buy | Buy | maintain |